Related Experiment Video
Updated: May 2, 2026
Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions
Published on: November 17, 2021
Targeted therapy in pediatric low-grade glioma
John-Paul Kilday1, Ute Katharina Bartels, Eric Bouffet
1Department of Haematology/Oncology, Royal Manchester Children's Hospital, Oxford Road, Manchester, M13 9WL, UK, john-paul.kilday@cmft.nhs.uk.
Abstract:
Collectively, pediatric low-grade gliomas account for most brain tumors reported in children. Surgery is typically curable for operable lesions. However, more effective therapies are required for inaccessible tumors, both to overcome refractory disease and to minimize the toxicity associated with conventional adjuvant chemotherapy and radiotherapy regimens. Recent years have witnessed rapid improvements in our understanding of the molecular pathogenesis of several childhood tumors, including low-grade gliomas. As a result, several novel compounds targeting and inhibiting critical components of molecular signaling pathways purported to be overactive in the disease have been developed. This article summarizes the most recent literature evaluating such novel targeted agents in childhood low-grade gliomas.
Insights
Pediatric low-grade gliomas are common childhood brain tumors. Novel targeted therapies show promise for treating inaccessible tumors and reducing treatment toxicity.
Area of Science:
- Pediatric oncology
- Neuro-oncology
- Molecular targeted therapy
Background:
- Pediatric low-grade gliomas represent the majority of brain tumors in children.
- While surgery is effective for operable tumors, advanced therapies are needed for unresectable or refractory cases.
- Conventional treatments like chemotherapy and radiotherapy can cause significant toxicity in children.
Purpose of the Study:
- To review recent literature on novel targeted agents for childhood low-grade gliomas.
- To highlight advancements in understanding the molecular drivers of these tumors.
- To discuss therapeutic strategies that minimize toxicity compared to traditional regimens.
Main Methods:
- Literature review of recent studies on targeted therapies for pediatric low-grade gliomas.
- Analysis of novel compounds targeting specific molecular pathways implicated in glioma development.
- Evaluation of treatment efficacy and toxicity profiles of emerging agents.
Main Results:
- Significant progress has been made in identifying molecular targets in pediatric low-grade gliomas.
- Several novel targeted agents are under investigation, showing promising preliminary results.
- These targeted therapies aim to improve outcomes for children with difficult-to-treat gliomas.
Conclusions:
- Targeted therapies represent a promising new frontier in treating pediatric low-grade gliomas.
- Further research is crucial to optimize these novel agents and integrate them into clinical practice.
- The development of targeted treatments offers hope for improved efficacy and reduced side effects in pediatric neuro-oncology.
More Related Videos
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:57Targeted Cancer Therapies